Stevanato Group (NYSE:STVN – Get Free Report) and Delcath Systems (NASDAQ:DCTH – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Institutional and Insider Ownership 61.1% of Delcath Systems […]
NEW YORK, May 3, 2024 /PRNewswire/ Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company.
/PRNewswire/ Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and.
Stevanato Group (NYSE:STVN – Get Free Report) and Delcath Systems (NASDAQ:DCTH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings. Valuation & Earnings This table compares Stevanato Group […]